1. Home
  2. ALTI vs ABSI Comparison

ALTI vs ABSI Comparison

Compare ALTI & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$2.99

Market Cap

492.8M

Sector

Finance

ML Signal

HOLD

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$9.56

Market Cap

997.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTI
ABSI
Founded
2020
2011
Country
United States
United States
Employees
490
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.8M
997.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ALTI
ABSI
Price
$2.99
$9.56
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $6.96
AVG Volume (30 Days)
149.0K
★ 3.4M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.11
10.64
EPS
★ N/A
N/A
Revenue
★ $254,956,000.00
$4,534,000.00
Revenue This Year
$18.06
$215.96
Revenue Next Year
$10.71
$319.10
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 23.21
N/A
52 Week Low
$2.75
$2.24
52 Week High
$5.45
$12.06

Technical Indicators

Market Signals
Indicator
ALTI
ABSI
Relative Strength Index (RSI) 35.35 53.26
Support Level $2.93 $8.17
Resistance Level $3.94 $10.03
Average True Range (ATR) 0.12 0.72
MACD -0.01 0.08
Stochastic Oscillator 6.82 51.08

Price Performance

Historical Comparison
ALTI
ABSI

About ALTI AlTi Global Inc.

AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Share on Social Networks: